Mindbloom’s Dylan Beynon: Unlocking Mental Health with Psychedelic Therapy
I know without a doubt that I would not be who I am or where I am today...if I hadn't maybe plugged those jumper cables onto myself and then leveraged these medicines over the past years to increase my neuroplasticity and open myself up emotionally and as a pillar of my own mental health care development.
Picture this: you’re stuck in a mental rut, and nothing seems to help. Enter Dylan Beynon, the founder and CEO of Mindbloom, who joins Duane Osterlind on The Addicted Mind Podcast to discuss a groundbreaking approach to mental health care. Dylan shares his own eye-opening experience with MDMA and how it set him on a mission to harness the power of psychedelics for healing.
He dives into how ketamine therapy can break through trauma and addiction by opening up the brain’s neuroplasticity, essentially helping people to think in new ways. With an impressive response rate for depression symptoms, Dylan explains how Mindbloom aims to make these treatments accessible and affordable. But what’s the difference between recreational and therapeutic use? Dylan breaks it down, emphasizing the importance of intention-setting and preparation in psychedelic therapy.
He also highlights the stages of recovery and the necessity of long-term support for lasting change. Safety, risks, and the future of psychedelic treatments are all on the table in this thought-provoking conversation. Tune in to discover how Mindbloom is paving the way for a new era in mental health care.